DNP Biotech Overview

  • Founded
  • 2006

Founded
  • Status
  • Private

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 4

DNP Biotech General Information

Description

Developer of molecular diagnostics DNA (Deoxyribonucleic acid) biomarkers designed to provide customized treatments. The company's molecular diagnostics DNA biomarkers are effective and help to detect and manage lung cancer, enabling patients to begin the treatment more quickly and resulting in a higher likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
  • Songpa-daero, Songpa-gu
  • Room B608, 6th floor, Building B, 167
  • Seoul, 05836
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DNP Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DNP Biotech‘s full profile, request access.

Request a free trial

DNP Biotech Executive Team (1)

Name Title Board Seat Contact Info
Lee Myung-hoon Chief Executive Officer
To view DNP Biotech’s complete executive team members history, request access »

DNP Biotech Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DNP Biotech‘s full profile, request access.

Request a free trial